S.No | 1.PRODUCT 2nd generation of CAR T Cells Therapy | Discovery stage and Early process development | Preclinical | Clinical trials |
1 | LB101 Development of Commercial Novel huanti-CAR19T-CD27/41-BB-CD3Z Cells Therapy: Towards Enhanced Efficacy and Safety |
50% Complete
| 2027 |